Windward Bio Group AG lists on Nasdaq on November 13, 2026, following a US IPO and a private placement that raised about $225 million, according to the reports. The company priced the IPO at $17.00 per share, and in its first US trading day shares rose in the debut period.
Bloomberg and PR Newswire both describe the transaction and the early market reaction, though they emphasize different details. Bloomberg highlights the capital raised and the reported share move at the start of trading, including a rise of 7.9% in its debut. PR Newswire focuses on the listing event and the IPO pricing and closing performance, presenting the results as part of the company’s successful start on Nasdaq.